Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance

被引：29

作者：

Asano, Takaki ^{[1
]}

Khourieh, Joelle ^{[2
,3
]}

Zhang, Peng ^{[1
]}

Rapaport, Franck ^{[1
]}

Spaan, Andras N. ^{[1
]}

Li, Juan ^{[1
]}

Lei, Wei-Te ^{[1
]}

Pelham, Simon J. ^{[1
]}

Hum, David ^{[1
]}

Chrabieh, Maya ^{[2
,3
]}

Han, Ji Eun ^{[1
]}

Guerin, Antoine ^{[4
,5
]}

Mackie, Joseph ^{[4
,5
]}

Gupta, Sudhir ^{[6
]}

Saikia, Biman ^{[7
]}

Baghdadi, Jamila E., I ^{[8
]}

Fadil, Ilham ^{[9
,10
]}

Bousfiha, Aziz ^{[9
,10
]}

Habib, Tanwir ^{[11
]}

Marr, Nico ^{[11
,12
]}

Ganeshanandan, Luckshman ^{[13
]}

Peake, Jane ^{[14
]}

Droney, Luke ^{[15
]}

Williams, Andrew ^{[16
]}

Celmeli, Fatih ^{[17
]}

Hatipoglu, Nevin ^{[18
]}

Ozcelik, Tayfun ^{[19
]}

Picard, Capucine ^{[20
,21
,22
,23
]}

Abel, Laurent ^{[1
,2
,3
]}

Tangye, Stuart G. ^{[4
,5
]}

Boisson-Dupuis, Stephanie ^{[1
,2
,3
]}

Zhang, Qian ^{[1
,2
,3
]}

Puel, Anne ^{[1
,2
,3
]}

Beziat, Vivien ^{[1
,2
,3
]}

Casanova, Jean-Laurent ^{[1
,2
,3
,24
]}

Boisson, Bertrand ^{[1
,2
,3
]}

机构：

[1] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA

[2] Paris Univ, Imagine Inst, Paris, France

[3] Inst Natl Sante & Rech Med U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France

[4] Garvan Inst Med Res, Darlinghurst, NSW, Australia

[5] Univ New South Wales, Fac Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia

[6] Univ Calif Irvine, Sch Med, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA

[7] Post Grad Inst Med Educ & Res, Dept Immunopathol, Chandigarh, India

[8] Mil Hosp Mohamed V, Genet Unit, Rabat, Morocco

[9] King Hassan II Univ, Fac Med & Pharm Casablanca, Lab Clin Immunol Inflammat & Allergy, Casablanca, Morocco

[10] Averroes Univ Hosp Ctr, Childrens Hosp, Dept Pediat Infect Dis, Clin Immunol Unit, Casablanca, Morocco

[11] Qatar Fdn, Res Branch, Sidra Med, Doha, Qatar

[12] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Hlth & Life Sci, Doha, Qatar

[13] Fiona Stanley Hosp, Dept Clin Immunol, PathWest Lab Med Western Australia, Perth, WA, Australia

[14] Queensland Childrens Hosp, South Brisbane, Australia

[15] Princess Alexandra Hosp, Dept Clin Immunol, Brisbane, Qld, Australia

[16] Childrens Hosp Westmead, Immunol Lab, Westmead, NSW, Australia

[17] Univ Med Sci Antalya Educ & Res Hosp, Dept Allergy & Immunol, Antalya, Turkey

[18] Bakirkoy Dr Sadi Konuk Educ & Training Hosp, Istanbul, Turkey

[19] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey

[20] Univ Paris, Paris, France

[21] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Study Ctr Primary Immunodeficiencies, Paris, France

[22] Inst Natl Sante & Rech Med UMR 1163, Imagine Inst, Lab Lymphocyte Activat & Susceptibil EBV Infect, Paris, France

[23] Necker Hosp Sick Children, Assistance Publ Hop Paris, Pediat Immunol Hematol Unit, Paris, France

[24] Howard Hughes Med Inst, New York, NY 10032 USA

来源：

JOURNAL OF EXPERIMENTAL MEDICINE | 2021年 / 218卷 / 08期

基金：

荷兰研究理事会; 美国国家卫生研究院;

关键词：

HYPERIMMUNOGLOBULIN-E SYNDROME; SIGNAL TRANSDUCER; CLINICAL-FEATURES; POINT MUTATIONS; KEY FINDINGS; GENE; DEFICIENCY; DOCK8; ACTIVATOR; PATIENT;

D O I：

10.1084/jem.20202592

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Most patients with autosomal dominant hyper-IgE syndrome (AD-HIES) carry rare heterozygous STAT3 variants. Only six of the 135 in-frame variants reported have been experimentally shown to be dominant negative (DN), and it has been recently suggested that eight out-of-frame variants operate by haploinsufficiency. We experimentally tested these 143 variants, 7 novel out-of-frame variants found in HIES patients, and other STAT3 variants from the general population. Strikingly, all 15 out-of-frame variants were DN via their encoded (1) truncated proteins, (2) neoproteins generated from a translation reinitiation codon, and (3) isoforms from alternative transcripts or a combination thereof. Moreover, 128 of the 135 in-frame variants (95%) were also DN. The patients carrying the seven non-DN STAT3 in-frame variants have not been studied for other genetic etiologies. Finally, none of the variants from the general population tested, including an out-of-frame variant, were DN. Overall, our findings show that heterozygous STAT3 variants, whether in or out of frame, underlie AD-HIES through negative dominance rather than haploinsufficiency.

引用

页数：28

共 50 条

[1] Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome
Staudacher, Olga
Krueger, Renate
Koelsch, Uwe
Thee, Stephanie
Gratopp, Alexander
Wahn, Volker
Lau, Susanne
von Bernuth, Horst
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 349 - +
[2] A Novel Mutation in STAT3 in a Family with Autosomal Dominant Hyper-IgE Syndrome
Kovalszki, A.
Hsu, A. P.
Holland, S. M.
Baptist, A. P.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB73 - AB73
[3] Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome
Bocchini, Claire E.
Nahmod, Karen
Katsonis, Panagiotis
Kim, Sang
Kasembeli, Moses M.
Freeman, Alexandra
Lichtarge, Olivier
Makedonas, George
Tweardy, David J.
[J]. BLOOD, 2016, 128 (26) : 3061 - 3072
[4] Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency
Dureault, Amelie
Tcherakian, Colas
Poiree, Sylvain
Catherinot, Emilie
Danion, Francois
Jouvion, Gregory
Bougnoux, Marie Elisabeth
Mahlaoui, Nizar
Givel, Claire
Castelle, Martin
Picard, Capucine
Chansdesris, Marie Olivia
Lortholary, Olivier
Lanternier, Fanny
Coignard, H.
Amazzough, K.
Suarez, F.
Blanche, S.
Sendid, B.
Cornu, M.
Bervar, J. F.
Deschildre, A.
Wemeau, L.
Fieschi, C.
Alanio, A.
Menetrey, C.
Senechal, A.
Ader, F.
Tattevin, P.
Pison, C.
Grandiere-Perez, L.
Garcia-Hermoso, D.
Botterel-Chartier, F.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1986 - +
[5] Dominant negative STAT-3 mutations in hyper-IgE syndrome
Dereure, O.
[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (05): : 432 - 432
[6] Mutations underlying autosomal dominant hyper-IgE syndrome impair distinct stages of STAT3 signaling
Pelham, S. J.
Lenthall, H.
Deenick, E. K.
Tangye, S. G.
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 139 - 140
[7] STAT3 signaling and the hyper-IgE syndrome
Levy, David E.
Loomis, Cynthia A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1655 - 1658
[8] STAT3 mutations in the hyper-IgE syndrome
Holland, Steven M.
Deleo, Frank R.
Elloumi, Houda Z.
Hsu, Amy P.
Uzel, Gulbu
Brodsky, Nina
Freeman, Alexandra F.
Demidowich, Andrew
Davis, Joie
Turner, Maria L.
Anderson, Victoria L.
Darnell, Dirk N.
Welch, Pamela A.
Kuhns, Douglas B.
Frucht, David M.
Malech, Harry L.
Gallin, John I.
Kobayashi, Scott D.
Whitney, Adeline R.
Voyich, Jovanka M.
Musser, James M.
Woellner, Cristina
Schaeffer, Alejandro A.
Puck, Jennifer M.
Grimbacher, Bodo
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1608 - 1619
[9] AN ATYPICAL PRESENTATION OF STAT3 HYPER-IGE SYNDROME
Van Mason, J.
Raje, N.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S121 - S121
[10] STAT3 haploinsufficiency is associated with autosomal-dominant hyper IgE syndrome
Fliegauf, M.
Glocker, C.
Saghafi, S.
Gonschorek, S.
Froebel, P.
Lammich, K.
Rojas-Restrepo, J.
Neubauer, J.
Bulashevska, A.
Franke, A.
Weidinger, S.
Pourpak, Z.
Grimbacher, B.
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 172 - 172

← 1 2 3 4 5 →